Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors
The Journal of Steroid Biochemistry and Molecular Biology · 2024
DOI: 10.1016/j.jsbmb.2024.106544 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2024. Verfasst von Jean-Yves Sancéau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Organic Synthesis Service, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada; Endocrinology and Nephrology Unit, CHU de Québ…. Hauptthemen laut MEDLINE: 17-Hydroxysteroid Dehydrogenases, Enzyme Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR.
Abstract (Originalsprache)
Sex steroid hormones such as estrogen estradiol (E2) and androgen dihydrotestosterone (DHT) are involved in the development of hormone-dependent cancers. Blockade of 17β-hydroxysteroid dehydrogenase type 7 (17β-HSD7), a member of the short chain dehydrogenase/reductase superfamily, is thought to decrease E2 levels while increasing those of DHT. Therefore, its unique double action makes this enzyme as an interesting drug target for treatment of breast cancer. The chemical synthesis, molecular characterization, and preliminary biological evaluation as 17β-HSD7 inhibitors of novel carbamate derivatives 3 and 4 are described. Like previous 17β-HSD7 inhibitors 1 and 2, compounds 3 and 4 bear a hydrophobic nonyl side chain at the C-17β position of a 4-aza-5α-androstane nucleus, but compound 3 has an oxygen atom replacing the CH2 in the steroid A-ring C-2 position, while compound 4 has a C17-spiranic E-ring containing a carbamate function. They both inhibited the in vitro transformation of estrone (E1) into E2 by 17β-HSD7, but the introduction of a (17 R)-spirocarbamate is preferable to replacing C-2 methylene with an oxygen atom since compound 4 (IC50 = 63 nM) is an inhibitor 14 times more powerful than compound 3 (IC50 = 900 nM). Furthermore, when compared to the reference inhibitor 1 (IC50 = 111 nM), the use of a C17-spiranic E-ring made it possible to introduce differently the hydrophobic nonyl side chain, without reducing the inhibitory activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Organic Synthesis Service, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada; Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada.
- Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada.
- Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada.
- Organic Synthesis Service, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada; Endocrinology and Nephrology Unit, CHU de Québec Research Center-Université Laval, Québec, QC G1V 4G2, Canada; Depar…
Förderung
- CIHR
Zitieren
APA
Sancéau, J. Y., Maltais, R., Zhou, M., Lin, S. X., & Poirier, D. (2024). Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2024.106544
Vancouver
Sancéau JY, Maltais R, Zhou M, Lin SX, Poirier D. Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 2024. doi:10.1016/j.jsbmb.2024.106544
BibTeX
@article{Sancau2024,
author = {Sancéau, Jean-Yves and Maltais, René and Zhou, Ming and Lin, Sheng-Xiang and Poirier, Donald},
title = {Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors},
journal = {The Journal of Steroid Biochemistry and Molecular Biology},
year = {2024},
doi = {10.1016/j.jsbmb.2024.106544}
}
EUVIMED